Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5924183 | 0.84 | GAA (0.38) | GAAKMT2AMEN1MAPK1NPC1 | |
| SCHEMBL9847096 | 0.80 | HTT (0.54) | GAAKMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL31558761 | 0.79 | GAA (0.38) | GAAKMT2AMEN1MAPK1LMNA | |
| SCHEMBL31558756 | 0.79 | HSP90AA1 (0.58) | GAAKMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL9711371 | 0.79 | HSP90AA1 (0.58) | GAAKMT2AMEN1NPC1ALDH1A1 | |
| SCHEMBL8256589 | 0.79 | GAA (0.43) | GAAKMT2AMEN1MAPK1LMNA | |
| SCHEMBL9872347 | 0.77 | AGTR1 (0.37) | GAALMNANPC1AGTR1MAPT | |
| SCHEMBL22853792 | 0.77 | LMNA (0.64) | GAAKMT2AMEN1MAPK1LMNA | |
| SCHEMBL3266109 | 0.74 | MAPT (0.53) | GAAKMT2AMEN1MAPK1LMNA | |
| SCHEMBL20065125 | 0.73 | GAA (0.38) | GAAKMT2AMEN1NPC1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250185660-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING HERBIVOROUS PESTS AND REDUCING CROP DAMAGE USING PREDATORY INSECT SEMIOCHEMICALS | THE PENN STATE RESEARCH FOUNDATION | 2025-06-12 | — | — | US | claimed |
| CN-118448722-A | Functional oxidation-reduction shuttle additive and preparation method thereof, and novel electrolyte for lithium ion battery | 盘锦富隆化工有限公司 | 2024-08-06 | — | — | CN | claimed |
| WO-2024044693-A2 | METHODS AND COMPOSITIONS FOR DISRUPTING HERBIVOROUS PESTS AND REDUCING CROP DAMAGE USING PREDATORY INSECT SEMIOCHEMICALS | THE PENN STATE RESEARCH FOUNDATION (US) | 2024-02-29 | — | — | WO | claimed |
| CN-111521699-B | Fatty acid LC-MS/MS analysis method based on double-derivatization technology | 首都医科大学附属北京朝阳医院 | 2022-06-07 | — | — | CN | claimed |
| CN-110950913-B | Ionic metal complex with 9-aldehyde-10-pyrimidinehydrazone as ligand and synthetic method and application thereof | 广西师范大学 | 2021-06-18 | — | — | CN | claimed |
| CN-110950896-B | Copper (II) complex with 9-aldehyde-10-pyrimidinehydrazone as ligand and synthetic method and application thereof | 广西师范大学 | 2021-05-14 | — | — | CN | claimed |
| CN-111521699-A | Fatty acid LC-MS/MS analysis method based on double-derivative technology | 首都医科大学附属北京朝阳医院 | 2020-08-11 | — | — | CN | claimed |
| CN-110950913-A | Ionic metal complex with 9-aldehyde-10-pyrimidinehydrazone as ligand and synthetic method and application thereof | 广西师范大学 | 2020-04-03 | — | — | CN | claimed |
| CN-110950896-A | Copper (II) complex with 9-aldehyde-10-pyrimidinehydrazone as ligand and synthetic method and application thereof | 广西师范大学 | 2020-04-03 | — | — | CN | claimed |
| US-20250185660-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING HERBIVOROUS PESTS AND REDUCING CROP DAMAGE USING PREDATORY INSECT SEMIOCHEMICALS | THE PENN STATE RESEARCH FOUNDATION | 2025-06-12 | — | — | US | disclosed |
| CN-120004811-A | Novel method for synthesizing 2-hydrazino-substituted pyrimidine | 凯里学院 | 2025-05-16 | — | — | CN | disclosed |
| CN-118126023-B | Pyrazole amide compound as well as preparation method and application thereof | 安徽中医药大学 | 2025-04-11 | — | — | CN | disclosed |
| US-12171229-B2 | Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides | BAYER AKTIENGESELLSCHAFT (DE) | 2024-12-24 | — | — | US | disclosed |
| CN-118955469-A | Pyrazole alcohol compound as well as preparation method and application thereof | 安徽中医药大学 | 2024-11-15 | — | — | CN | disclosed |
| EP-0457140-A2 | Phenoxyphenyl sulfonyl compounds | BAYER AG (DE) | 1991-11-21 | — | — | EP | disclosed |
| EP-0293743-B1 | SUBSTITUTED 5-AMINO-PYRAZOLES AND FUNGICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1991-08-14 | — | — | EP | disclosed |
| US-5021082-A | Pre=and postemergent | BAYER AKTIENGESELLSCHAFT (DE) | 1991-06-04 | — | — | US | disclosed |
| EP-0419831-A2 | Substituted sulfonylaminoazoles | BAYER AG (DE) | 1991-04-03 | — | — | EP | disclosed |
| US-4941912-A | Herbicidal substituted sulphonylaminoazoles | BAYER AKTIENGESELLSCHAFT (DE) | 1990-07-17 | — | — | US | disclosed |
| EP-0293743-A1 | Substituted 5-amino-pyrazoles and fungicides containing them | BASF Aktiengesellschaft (DE) | 1988-12-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12171229-B2 | Heteroaryl-triazole and heteroaryl-tetrazole compounds as pesticides | CYP4F3, TARS2, TH | GAA 2510/4885KMT2A 2141/4885MEN1 3871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.